-
Signature
-
/s/ Stephen Vander Stoep, attorney-in-fact for Joseph Shulman
-
Issuer symbol
-
RYTM
-
Transactions as of
-
30 Oct 2025
-
Net transactions value
-
-$824,524
-
Form type
-
4
-
Filing time
-
03 Nov 2025, 16:30:15 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Shulman Joseph |
Chief Technical Officer |
C/O RHYTHM PHARMACEUTICALS, INC., 222 BERKELEY STREET, 12TH FLOOR, BOSTON |
/s/ Stephen Vander Stoep, attorney-in-fact for Joseph Shulman |
03 Nov 2025 |
0001909855 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RYTM |
Common Stock |
Options Exercise |
$298,874 |
+9,748 |
+115% |
$30.66 |
18,257 |
30 Oct 2025 |
Direct |
|
| transaction |
RYTM |
Common Stock |
Sale |
$1,123,398 |
-9,748 |
-53% |
$115.24 |
8,509 |
30 Oct 2025 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RYTM |
Stock Options (Right to Buy) |
Options Exercise |
$0 |
-9,748 |
-100% |
$0.000000 |
0 |
30 Oct 2025 |
Common Stock |
9,748 |
$30.66 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: